ID A549-iRFP-Puro AC CVCL_QZ85 DR cancercelllines; CVCL_QZ85 DR Imanis; CL082 DR Wikidata; Q54607035 CC Population: Caucasian. CC Characteristics: Reporter cell line, transduced with the LV-iRFP-P2A-Puro vector encoding for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL082). CC Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line). CC Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris). CC Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; S.alboniger pac (PuroR). CC Derived from site: In situ; Lung; UBERON=UBERON_0002048. DI NCIt; C3512; Lung adenocarcinoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_0023 ! A-549 SX Male AG 58Y CA Cancer cell line DT Created: 05-03-18; Last updated: 19-12-24; Version: 12 //